MDT
Medtronic plc
Revenue by segment
FY2026, ended Apr 24, 2026
Earlier:
Segments by fiscal year
| USDLine, in USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable segment net sales | 33.1B | 30.7B | 29.7B | 30.7B | 31.0B | — | — | — | — | — | — | — | — | — |
Cardiovascular | 14.0B | 12.5B | 11.8B | 11.5B | 11.4B | 10.8B | 10.5B | 11.5B | — | — | — | — | — | — |
Neuroscience | 10.3B | 9.8B | 9.4B | 9.0B | 8.8B | 8.2B | 7.7B | 8.2B | — | — | — | — | — | — |
Medical Surgical | 8.82B | 8.41B | 8.42B | 7.99B | 8.47B | 8.74B | 8.35B | 8.48B | — | — | — | — | — | — |
| Other Operating Segments, Including Diabetes | 3.25B | 2.89B | 2.71B | — | — | — | — | — | — | — | — | — | — | — |
Diabetes | 3.11B | 2.76B | 2.49B | 2.26B | 2.34B | 2.41B | 2.37B | 2.39B | 2.14B | 1.93B | 1.86B | 1.76B | 1.66B | 1.53B |
Other operating segment, misc | 135M | — | — | — | — | — | — | — | — | — | — | — | — | — |
Other Operating Segments | — | 138M | 222M | 495M | 727M | — | — | — | — | — | — | — | — | — |
| Other Adjustments | 39M | −90M | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | 27.8B | 27.8B | 27.0B | 18.5B | 15.3B | 15.1B | |
| Cardiac & Vascular Group | — | — | — | — | — | — | — | — | 11.4B | 10.5B | 10.2B | 9.4B | 8.8B | 8.7B |
| Minimally Invasive Therapies Group | — | — | — | — | — | — | — | — | 8.72B | 9.92B | 9.56B | 2.39B | — | — |
| Restorative Therapies Group | — | — | — | — | — | — | — | — | 7.74B | 7.37B | 7.21B | 6.75B | 6.50B | 6.37B |
| Total | 36.4B | 33.5B | 32.4B | 31.2B | 31.7B | 30.1B | 28.9B | 30.6B | 30.0B | 29.7B | 28.8B | 20.3B | 17.0B | 16.6B |